Similar articles

• Doxorubicin, bleomycin, vinblastine, and dacarbazine alone in treatment of favorable, limited-stage Hodgkin's lymphoma: do we really have robust data?

  Basaran G, Agaoglu F, Basaran M. Basaran G, et al. J Clin Oncol. 2010 Sep 20;28(27):e485-6; author reply e487. doi: 10.1200/JCO.2010.29.0304. Epub 2010 Jul 6. J Clin Oncol. 2010. PMID: 20606082 No abstract available.
• Consolidation radiotherapy may improve outcomes in people with Hodgkin's disease achieving complete remission after combination chemotherapy.

  Specht L. Specht L. Cancer Treat Rev. 2004 Aug;30(5):479-82. doi: 10.1016/j.ctrv.2004.05.006. Cancer Treat Rev. 2004. PMID: 15245780 Clinical Trial. No abstract available.
• Primary cutaneous Hodgkin's lymphoma.

  Mukesh M, Shuttleworth D, Murray P. Mukesh M, et al. Clin Exp Dermatol. 2009 Dec;34(8):e673-5. doi: 10.1111/j.1365-2230.2009.03402.x. Epub 2009 Oct 10. Clin Exp Dermatol. 2009. PMID: 19817768 Review.
• Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.

  Comella P, Abate G, Fiore M, Di Finizio G, Frezza P, Scoppa G, Anania C, Coucourde F, Zarrilli D. Comella P, et al. J Chemother. 1989 Jul;1(4 Suppl):1254-6. J Chemother. 1989. PMID: 16312855 No abstract available.
• [Primary treatment of early stage Hodgkin's disease].

  Molnár Z, Esik O, Illés A. Molnár Z, et al. Orv Hetil. 2005 Jan 9;146(2):57-61. Orv Hetil. 2005. PMID: 15724953 Review. Hungarian.